Bing

Seven stocks lost value in Bermuda Stock Exchange trading last week — but The Royal Gazette/BSX Index still managed to eke out a small gain. That was down to the one stock that gained, Butterfield Bank, which …
The Royal Gazette · 13 hours ago
BSX stocks
NEW YORK (TheStreet) -- Boston Scientific Corp. stock was upgraded to "buy" from "neutral" with a price target of $20 at Goldman Sachs this morning. The firm remains constructive on MedTech going into the rest of the year and believes Boston Scientific …
Finanzen · 8/27/2015
NEW YORK ( TheStreet) -- Jim Cramer answered viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO - Get Report), Celgene (CELG - Get Report) and Boston Scientific (BSX - Get Report), and on …
The Street · ByJim Cramer · 7 hours ago
Cramer
More from Bing News
Medtronic Inc (MDT): MDT stock is down 2.9% today. Smith & Nephew Snats (SNN): SNN stock is down 2.7% today. Boston Scientific Corp (BSX): BSX stock is down 2.6% today. Resmed Inc (RMD): RMD stock is down 2.5% today. Edwards …
Investor Place · 8 hours ago
Goldman Sachs’ price target suggests a potential upside of 17.16% from the stock’s previous close. The analysts noted that the move was a valuation call. A number of other brokerages have also weighed in on BSX. Benchmark Co. boosted their target …
wkrb13.com · 8/29/2015
Boston Scientific (NYSE:BSX) Director John E. Abele purchased 200,000 shares of Boston Scientific stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average price of $17.48 per share, with a total value of $ ...
sleekmoney.com · 8/21/2015
Boston Scientific (NYSE:BSX) was upgraded by equities researchers at Goldman Sachs to a “buy” rating in a report released on Thursday, The Fly reports. The firm presently has a $20.00 price objective on the stock. Goldman Sachs’ price target would ...
Ticker Report · 8/27/2015
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Boston Scientific Corp. (NYSE:BSX) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $14.1801 per share.
Market News Video · 8/24/2015
Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), Boston Scientific (BSX), and on why September is a tough month on Wall Street. A viewer asked about Qorvo. Cramer …
11 Alive · 7 hours ago
Jim Cramer
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Boston Scientific ( BSX), a filing with the SEC revealed ...
NASDAQ · 8/19/2015

Boston Scientific

The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used …
The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Data from: Wikipedia · Freebase